Drug Screening Market size to grow by USD 6.6599 billion from 2022 to 2027, Advancements in Drug Screening Technologies to Influence Market Growth, Technavio

NEW YORK, March 6, 2024 /PRNewswire/ -- The drug screening market is expected to grow by USD 6,659.87 million during the five-year forecast period, according to Technavio. As per the latest report, the market will progress at a CAGR of 16.97% during 2022-2027.  The integration of artificial intelligence (AI) and machine learning (ML) in drug screening is a major trend in the market. Drug screening processes are improved in accuracy, efficiency, and reliability using AI and ML algorithms. Using these systems, huge volumes of data and spot trends could be examined that could indicate drug use, producing more accurate results. Additionally, AI-based software can easily simplify data management and reporting, optimize overall workflow, and make drug trial decision-making smoother with AI. Hence, the integration of artificial intelligence (AI) and machine learning (ML) is expected to drive the growth of the market during the forecast period. 

View the new Sample Report within minutes!

The advancements in drug screening technologies are a key factor driving market growth. 

Drug sensitivity, specificity, and efficacy are factors driving innovation and advancement in testing equipment and procedures. Furthermore, through the incorporation of advanced analytical techniques such as liquid chromatography-mass spectrometry (LC-MS), the identification and quantification of drug compounds is accomplished. Drug dependence allows for better identification of a wide variety of substances and their metabolites due to these developments. Hence, advancements in drug screening technologies are expected to drive the growth of the market during the forecast period.

• The development of alternative testing methods is a significant challenge restricting market growth. 

Find more insights in a sample report!

Market Segmentation

• Type 
• Drug Screening Products
• Drug Screening Services
• Application 
• Urine Samples
• Breath Samples
• Hair And Blood Samples
• Oral Fluid Samples
• Geography 
• North America
• Europe
• Asia
• Rest Of World (ROW)

The market share growth by the drug screening products segment will be significant during the forecast period. This segment includes test kits, analyzers, and consumables, and these are widely used for drug testing purposes. Demand for these items is steadily increasing due to increased drug abuse, tight restrictions, and concerns about worker safety. In addition, the demand for it's products has increased as the development of technology has developed more reliable solutions. Hence, these factors are expected to drive the growth of the segment during the forecast period.

Find more insights in a sample report!

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. We provide a detailed analysis of around 25 companies operating in the market, including Abbott Laboratories, Alfa Scientific Designs Inc, bioMerieux SA, Bio Rad Laboratories Inc., Bombardier Recreational Products Inc., Dragerwerk AG and Co. KGaA, F. Hoffmann La Roche Ltd., Healgen Scientific, LLC, Laboratory Corp. of America Holdings, Lifeloc Technologies Inc., LINEAR CHEMICALS S.L.U, Lochness Medical Supplies Inc., Omega Laboratories, Inc., OraSure Technologies Inc., Premier Biotech Inc., Psychemedics Corp., Quest Diagnostics Inc., Shimadzu Corp., Siemens AG, and Thermo Fisher Scientific Inc. are some of the major market participants. Our research reports on the market are designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

• Alfa Scientific Designs Inc - The company offers drug testing which provides saliva, urine CUPs, and single-drug urine tests.
• Abbott Laboratories - The company offers drug testing kits and devices.
• Dragerwerk AG and Co. KGaA - The company offers Drager drug test 5000 which is carried out simply and quickly.

Analyst Review

In today's world, drug abuse and alcohol consumption pose significant challenges across various sectors, from workplaces to healthcare facilities. The rise in illicit drugs and instances of alcohol impairment has led to an increased demand for its products & services and workplace drug testing solutions. This surge is further amplified by the ongoing Covid-19 pandemic, which has reshaped priorities and accelerated the adoption of its measures.

Drug Treatment Centers and Hospitals are at the forefront of combating substance abuse, relying heavily on effective methods to diagnose and treat patients. Moreover, personal users are also turning to its tools for monitoring and managing their own substance intake, especially amidst the challenges posed by the pandemic.

In response to these growing concerns, pain management centers are integrating it into their protocols to ensure responsible medication use. Additionally, the need for its adoption has become paramount, driven by concerns over employee privacy and the need to maintain a safe and productive work environment.

However, the market hasn't been immune to disruptions. Supply chain disruptions have occasionally affected the availability of its products & services, highlighting the importance of robust supply chains in sustaining essential services. In such times, home drug tests have emerged as a convenient alternative, allowing individuals to conduct screenings from the comfort of their homes.

One innovative approach gaining traction is the fingerprint-based swab drug test, offering a non-invasive and efficient method for detecting substance use. This technology has the potential to revolutionize its processes, providing quick and reliable results.

Amidst these dynamics, the importance of alcohol and drug tests cannot be overstated. They serve as critical tools in safeguarding public health and safety, whether in workplaces, healthcare settings, or personal contexts. As stakeholders continue to navigate the complexities of substance abuse, the market remains resilient, driven by innovation and a collective commitment to addressing these challenges head-on.

Find more insights in a sample report!

Related Reports 

The companion diagnostics market is estimated to grow at a CAGR of 22.59% between 2022 and 2027. The market size is forecast to increase by USD 11,029.63 million. Furthermore, this report extensively covers market segmentation by end-user (life science, health centers, and others), indication (oncology, neurology, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The rising use of personalized medicine is a key factor driving market growth during the forecast period.
The cancer diagnostics market is estimated to grow at a CAGR of 11.3% between 2022 and 2027. The market size is forecast to increase by USD 12,626.21 million. Furthermore, this report extensively covers market segmentation by end-user (hospitals and clinics, and diagnostic laboratories), type (IVD, imaging, and IDT), and geography (North America, Europe, APAC, and the Rest of the World (ROW)). The high prevalence of cancer is a key factor driving market growth during the forecast period.

Table Of Contents :
1 Executive Summary
2 Landscape
3 Sizing
4 Historic Size
5 Five Forces Analysis
6 Segmentations
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio